Inter-individual Variability of In Vivo CYP2D6 Activity in Different Genotypes

Inter-individual Variability of In Vivo CYP2D6 Activity in Different Genotypes
复制标题

DOI:
10.2133/dmpk.dmpk-11-rg-078
复制
发表时间:
2012-08-25
影响因子:
2.1
通讯作者:
Sugiyama, Yuichi
Sugiyama, Yuichi
中科院分区:
医学4区
文献类型:
--
作者:
Chiba, Koji;Kato, Motohiro;Sugiyama, Yuichi

文献摘要

被引文献

相似文献

细胞色素P450 2D6 (CYP2D6)具有大量的遗传多态性,参与多种底物的代谢。右美沙芬(DM)是一种众所周知的CYP2D6探测药物,代谢比(MR)常被用来测量体内CYP2D6酶的活性。利用DM MR的文献值,通过蒙特卡罗模拟估计各基因型CYP2D6肝内清除率(CLint,h,2D6)的个体间变异性,发现CYP2D6*1纯合子和CYP2D6*1杂合子与零等位基因的变异系数(CV)分别为43%和56%。CYP2D6*2和CYP2D6*10纯合子的变异率分别为63%和66%,而CYP2D6*2与零等位基因和CYP2D6*10与零等位基因的杂合子的变异率分别为125%和109%。基于亚洲人和高加索人CYP2D6基因型的变异性和报告频率,广泛代谢产物CLint,h,2D6的个体间变异性估计为60 - 70%,这提供了与DM,托特罗定,利培酮和托莫西汀的文献值相当的AUC变异性。这表明,每个基因型中CLint,h,2D6的个体间变异性有助于估计区域人群中CYP2D6底物的AUC变异性。
Cytochrome P450 2D6 (CYP2D6), which has a large number of genetic polymorphisms, is involved in the metabolism of a wide range of substrates. Dextromethorphan (DM) is a well-known probe drug for CYP2D6 and metabolic ratio (MR) is often used to measure the enzyme activity in vivo. Using the literature values of DM MR, we estimated the inter-individual variability of CYP2D6 hepatic intrinsic clearance (CLint,h,2D6) in each genotype by Monte Carlo simulation and found that the homozygote of CYP2D6*1 and the heterozygote of CYP2D6*1 and null alleles had a coefficient of variation (CV) of 43% and 56%, respectively. The variability of homozygotes of CYP2D6*2 and CYP2D6*10 was 63% and 66%, while that of the heterozygotes of CYP2D6*2 and null alleles and CYP2D6*10 and null alleles was 125% and 109%, respectively. Based on the variability and reported frequency of the CYP2D6 genotype in Asians and Caucasians, the inter-individual variability of CLint,h,2D6 of extensive metabolizers was estimated at 60 70%, which provided comparable variability of AUC with the literature values of DM, tolterodine, risperidone and atomoxetine. It is suggested that the produced inter-individual variability of CLint,h,2D6 in each genotype is useful for estimating AUC variability of the CYP2D6 substrates in the regional population.